Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Specialized Laboratory Analysis & Testing

Open
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract under the Defense Health Agency Contracting Activity involves providing specialized biomedical testing, assays, and molecular analysis to support breast cancer research projects. The scope of work includes conducting genomic sequencing, protein analysis, histological staining, and both in vitro and in vivo experiments. All activities must be performed in BSL-rated laboratories using specialized imaging equipment that meets NIH or DOD research standards. The selected provider is responsible for delivering comprehensive validated laboratory reports, raw data sets, and analyzed results. This effort falls under NAICS code 541380 and is designed to support prime contractors in executing critical research objectives for the Department of Defense.

General Info

Subcontract for specialized biomedical testing and molecular analysis supporting DOD breast cancer research.

Documents

This scope was carved out of HT942526BCRPBTA122.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Performs specialized biomedical testing, assays, and molecular analysis for prime contractors on Defense Health Agency (DHA) breast cancer research projects. Conducts in vitro or in vivo experiments, genomic sequencing, protein analysis, and histological staining. Requires BSL-rated laboratories and specialized imaging equipment adhering to NIH or DOD research standards. Delivers validated lab reports, raw data sets, and analyzed results.

Similar Contracts

Same NAICS industry code

NAICS: 541380
New
SLED
25-282903.FMD.StatewideLegionellaTesting
Solicitation # CR-25-282903
The California Department of General Services, Facilities Management Division (FMD) is soliciting bids for statewide Legionella sample collection, laboratory testing, analysis, and reporting for state-owned buildings and grounds. Operating across the Northern, Bay, and Southern regions, the contractor will provide as-needed routine and investigative sampling of domestic and non-potable water systems. Key deliverables include off-site laboratory analysis using a provided Chain of Custody Form, with results emailed within 48 hours of receipt and final survey reports submitted within 15 working days. All laboratories must be ELITE certified and AIHA Environmental Microbiology accredited, and testing must adhere to ISO 11731 standards. Final reports must be provided in a room-by-room format and signed by a Certified Industrial Hygienist (CIH). The contract will be awarded to the lowest responsive and responsible bidder, with a 3% Disabled Veteran Business Enterprise (DVBE) participation goal. Qualified personnel must include a Competent Professional and a Competent Technician as defined by the AIHA Technical Framework: Legionella (2020), and a CIH certified through the Board of Global Credentialing. Bidders must maintain significant insurance coverage, including $1,000,000 for Commercial General Liability, Pollution Liability, and Professional Liability. Performance is subject to prevailing wage rates and California Building Standards Code. Emergency service requests require a response within two hours. Payments are governed by Government Code Chapter 4.5, and a one-year warranty is required from the date of acceptance.
California Department of General Services

POSTED

about 13 hours ago

DEADLINE

in 16 days
View Details

More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca

Same awarding agency

NAICS: 541715
Grant
DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Solicitation # HT942526BCRPBTA122
The Defense Health Agency Contracting Activity is soliciting applications for the Fiscal Year 2026 Breast Cancer Research Program Breakthrough Award Levels 1 and 2 under solicitation HT942526BCRPBTA122. This program aims to fund high-impact research capable of producing breakthroughs in breast cancer treatment and understanding. Funding Level 1 supports early-stage, high-risk, high-reward research focused on proof of concept without requiring preliminary data, while Funding Level 2 supports research validated by substantial preliminary or published data to facilitate clinical translation. A specialized Population Science Studies option is available under Level 2. The program expects to allot approximately 10.6 million dollars to fund roughly six applications. Eligible applicants may apply as a single Principal Investigator or through a Partnering PI Option. Funding limits vary by level and PI structure, ranging from 750,000 dollars for a single PI at Level 1 up to 3.35 million dollars for partnering PIs conducting Population Science Studies at Level 2. The maximum period of performance is three years, extending to four years for Population Science Studies. Applications are evaluated based on impact, research strategy, and feasibility, with personnel and partnership qualifications also considered. The application process is a two-step submission requiring a pre-application by November 4, 2026, and a full application by November 18, 2026. Required documentation includes a project narrative, statement of work, and various abstracts and statements submitted as specific PDF attachments. Applicant organizations must maintain active registration in SAM.gov and provide a Unique Entity Identifier. Additionally, all key personnel must disclose foreign affiliations, and clinical research proposals must include a Public Health Service Inclusion Enrollment Report.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

2 months ago

DEADLINE

in 12 days
View Details
NAICS: 541715
Grant
DoW Breast Cancer, Clinical Research Extension Award
Solicitation # HT942526BCRPCREA2
The FY26 Breast Cancer Research Program Clinical Research Extension Award, solicitation HT942526BCRPCREA2, is a grant opportunity issued by the Defense Health Agency Contracting Activity to support research that extends data collection, follow-up, and analysis of breast cancer clinical studies. The program aims to recover knowledge lost due to early trial termination, limited patient follow-up, or suboptimal data collection, including projects involving deeper molecular analysis of clinical samples. All applications must address at least one FY26 BCRP overarching challenge. The research team is required to include at least two breast cancer consumer advocates. Funding allows for a single Principal Investigator or a partnering arrangement between an Initiating PI and a Partnering PI. The application process is a two-step submission requiring a pre-application Letter of Intent by November 4, 2026, and a full application by November 18, 2026. Pre-applications are submitted via eBRAP, while full applications are submitted through eBRAP for intramural DOW organizations and Grants.gov for extramural organizations. Awards have a maximum period of performance of four years. Evaluation follows a two-tier system consisting of a peer review for technical merit and a programmatic review for relevance. Scored criteria include impact, research strategy and feasibility, partnership (for PPIO applications), and the research sharing plan. Applicants must be registered in SAM.gov with an active status and a Unique Entity Identifier.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

2 months ago

DEADLINE

in 12 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS